Skip to Main Content

Paper Details

Sorafenib as an Inhibitor of RUVBL2.
Biomolecules
10
2020
Author NameAffiliation
Methvin IsaacOntario Institute for Cancer Research
Michael PrakeschOntario Institute for Cancer Research
Alessandro DattiUniversity of Perugia
Walid A HouryUniversity of Toronto
Walid A HouryUniversity of Toronto
  • 1 - 5

Datasets